Goldstone Psychiatry & Neuromodulation Center
Psychiatry & Neuromodulation Center
Neuromodulation & Interventional Psychiatry
Advanced Treatment for When Standard Care Hasn't Been Enough—Coming Soon
A different kind of treatment, for a different kind of problem.
Some depression, anxiety and other conditions doesn’t respond to medication and therapy alone. For those situations, neuromodulation and interventional psychiatry offer something fundamentally different — treatments that work on the brain’s circuits directly.
Goldstone Psychiatry & Neuromodulation Center is preparing to bring these advanced options to our patients. The full suite — Spravato (esketamine), and ketamine therapy — will launch in the months ahead.
✦ Coming Soon
These services are not yet active at Goldstone, but they’re on the way. If you’d like to be notified when each treatment becomes available — or to begin your evaluation now and have advanced options ready as soon as they launch — please reach out.
What's coming
Spravato (Esketamine). FDA-approved nasal spray for treatment-resistant depression. Delivered under clinical monitoring in our office, working through brain pathways that traditional antidepressants don’t touch.
Ketamine Therapy. A different mechanism for severe or treatment-resistant depression. Carefully screened, monitored, and integrated into a broader plan.
Why we're building this
Standard psychiatry helps most people, but not everyone. For patients who’ve tried multiple medications, attended therapy, made lifestyle changes, and still feel stuck — there should be a next step that isn’t just “try another medication.”
We’re building a neuromodulation program that combines clinical sophistication with the warmth and continuity that Goldstone is known for. These treatments work best when they’re part of a coordinated plan — not delivered in isolation.
Begin your care now
You don’t need to wait for our advanced services to launch to start. A psychiatric evaluation or treatment-resistant depression consultation today gives us time to:
- Get clear on your diagnosis and history
- Optimize your current treatment plan
- Identify whether you’d be a candidate for advanced options
- Have your plan ready to go the moment those services come online
Common questions
When will Spravato, and ketamine be available at Goldstone?
We’re targeting a phased launch in the coming months. The fastest way to know when each service goes live is to be on our notification list — ask us at your visit, or reach out through Send Query.
Should I wait to start care until those treatments are available?
No. Most patients benefit from beginning standard care now — careful diagnosis, medication optimization, and therapy planning. By the time advanced treatments are available, you’ll have a strong foundation in place and a clinician who already knows your story.
Will insurance cover these treatments?
Most commercial plans and Medicare cover standard TMS and Spravato for treatment-resistant depression when criteria are met. Accelerated TMS and ketamine therapy are typically self-pay. We’ll verify benefits and provide a written estimate before any treatment begins.
Get on the waitlist for Spravato, and ketamine therapy at Goldstone — or book an evaluation now so your plan is ready when these services launch.
All Services
- Psychiatric Evaluation
- Treatment-Resistant Depression Consultations
- Medication Management
- Medication Simplification & Deprescribing
- Telepsychiatry
- Neuromodulation and Interventional Psychiatry Treatments
- Second-Opinion & Diagnostic Clarification
- Executive, Professional & Athlete Support
- First Responder & Healthcare Worker Support
- Military & Veterans Mental Health
- Burnout, Stress & Performance Optimization
- Young Adult GPS Program
- Retirement Transition Support
Contact Us
(832) 300-8990
3120 Southwest Fwy, Ste. 617 Houston, TX 77098
Schedule online. It’s easy, fast and secure.